六味地黄颗粒对晚期肝肾阴虚型结直肠癌患者基因表达谱的差异分析

张立平, 马建文, 张洪亮

张立平, 马建文, 张洪亮. 六味地黄颗粒对晚期肝肾阴虚型结直肠癌患者基因表达谱的差异分析[J]. 实用临床医药杂志, 2014, (17): 52-55. DOI: 10.7619/jcmp.201417015
引用本文: 张立平, 马建文, 张洪亮. 六味地黄颗粒对晚期肝肾阴虚型结直肠癌患者基因表达谱的差异分析[J]. 实用临床医药杂志, 2014, (17): 52-55. DOI: 10.7619/jcmp.201417015
ZHANG Liping, MA Jianwen, ZHANG Hongliang. Difference analysis of Liuwei Dihuang Granule on the gene expression profile of patients with colorectal cancer due to yin deficiency of liver and kidney[J]. Journal of Clinical Medicine in Practice, 2014, (17): 52-55. DOI: 10.7619/jcmp.201417015
Citation: ZHANG Liping, MA Jianwen, ZHANG Hongliang. Difference analysis of Liuwei Dihuang Granule on the gene expression profile of patients with colorectal cancer due to yin deficiency of liver and kidney[J]. Journal of Clinical Medicine in Practice, 2014, (17): 52-55. DOI: 10.7619/jcmp.201417015

六味地黄颗粒对晚期肝肾阴虚型结直肠癌患者基因表达谱的差异分析

基金项目: 中国高校医学期刊临床专项资金项目(11321628);新疆维吾尔自治区自然科学基金面上项目
详细信息
  • 中图分类号: R735.3

Difference analysis of Liuwei Dihuang Granule on the gene expression profile of patients with colorectal cancer due to yin deficiency of liver and kidney

  • 摘要: 目的:筛选肝肾阴虚型晚期结直肠癌(CRC)患者使用六味地黄颗粒前后的基因表达谱差异,探索六味地黄颗粒药效的基因组学机制。方法选取晚期肝肾阴虚型CRC患者以六味地黄颗粒进行干预,21 d为1个疗程。干预期间患者不接受其他西医及中医药治疗。21 d后再次提取外周血,进行基因芯片检测,并与干预前芯片结果进行自身对照分析。结果与干预前相比,干预后基因芯片检测发现129个差异基因条,其中128个上调,1个下调。基因功能(GO)富集分析结果显示,干预前后共发现254个基因GO存在显著差异(P<0.05或P<0.01)。在生物过程中,凝血功能相关的基因占41.5%;在细胞组成中,45.5%的差异基因与细胞质膜有关;在分子功能方面,64.9%的差异基因与结合有关。结论晚期CRC肝肾阴虚型患者应用六味地黄颗粒干预前后存在差异表达基因,功能分析显示六味地黄颗粒可增强患者凝血功能,增加钙离子结合。
    Abstract: Objective The genomics mechanism of Liuwei Dihuang Granule efficacy was ex-plored by selecting the different gene expression profiles before and after the application of Liuwei Di-huang Granule for patients with advanced colorectal cancer (CRC)due to yin deficiency of liver and kidney.Methods Liuwei Dihuang Granule was given to patients with advanced CRC due to yin defi-ciency of liver and kidney,21 days as a course.During treatment,no western medicines or other Chi-nese medicines were administrated.21 days later,peripheral blood was collected again to detect the gene chips.Then the chips after intervention were compared with themselves before intervention.Re-sults Compared with intervention before,the chips after intervention had 129 differential gene frag-ments,in which 128 were up-regulated and 1 was down-regulated.Gene function enrichment anal-ysis showed that a total of 254 gene ontologies (GO)had significant differences before and after inter-ventions (P<0.05 orP<0.01).In the biological process,coagulation-related genes accounted for 41.5%.In cellular components,45.5%differential cells was associated with plasma membrane while in molecular function,64.9% was correlated with combination.Conclusion Patients with advanced CRC due to yin deficiency of liver and kidney have differential gene expressions before and after the in-terventions of Liuwei Dihuang Granule,and GO analysis indicates that Liuwei Dihuang Granule can strengthen the coagulation function and combination with calcium of CRC patients.
  • 段娟, 高思华. 对中医证候研究的一点认识 [J]. 广州中医药大学学报, 2009(5):497.doi: 10.3969/j.issn.1007-3213.2009.05.019.
    Gemoll T, Habermann J K, Becker S. Chromosomal aneuploidy affects the global proteome equilibrium of colorec-tal cancer cells [J]. Anal Cell Pathol (Amst), 2013(5):149.
    Deng Q, He B, Gao T. Up-Regulation of 91H Pro-motes Tumor Metastasis and Predicts Poor Prognosis for Pa-tients withColorectal Cancer [J]. PLoS One, 2014(7):e103022.
    杜标炎, 周瑶, 易华. 六味地黄丸入血成分对自杀基因杀伤肝癌细胞的增效作用 [J]. 中国实验方剂学杂志, 2013, (16):220.doi: 10.11653/syfj2013160220.
    赵益, 罗蓉, 朱卫丰. 六味地黄丸对肿瘤细胞抑制作用的研究 [J]. 中药新药与临床药理, 2011(6):598.
    杜欣, 杨宇飞, 许云. 中医药减少Ⅱ、Ⅲ期结直肠癌根治术后复发转移的用药规律分析 [J]. 世界科学技术-中医药现代化, 2014(1):21.doi: 10.11842/wst.2014.01.004.
    Hao YP, Zhang Y, Liu YM. Effect of Liuwei Dihuang pill on expression of NF-kappaB in kidney lesion induced by gentamicin in rats [J]. 中药材, 2010(1):86.
    郭慧君, 朱金华, 刘春花. 不同滋阴中药对小鼠诱发性肺肿瘤发生及抗肿瘤免疫功能的影响 [J]. 中国实验方剂学杂志, 2012, (13):226.doi: 10.3969/j.issn.1005-9903.2012.13.060.
    杜欣, 杨宇飞, 许云. 中医药减少Ⅱ、Ⅲ期结直肠癌根治术后复发转移的用药规律分析 [J]. 世界科学技术-中医药现代化, 2014(1):21.doi: 10.11842/wst.2014.01.004.
    徐小涵, 田国庆. 中药有效成分对结直肠癌的作用机制实验研究概况 [J]. 中医杂志, 2014(4):347.
    Salaga M, Zatorski H, Sobczak M. Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer:A Review [J]. Current Treat Options Oncology, 2014.
    李清华. 六味地黄丸联合FOLFOX6 方案治疗晚期胃癌 [J]. 新乡医学院学报, 2013(5):387.
    Guo Y, Zou Y, Xu Y F. Study on Chinese medicine syndrome of colorectal carcinoma in perioperative period [J]. Chin J Integr Med, 2014.
    Zhang W P, Yang H, Chen H. Gene expression analy-sis of potential genes and pathways involved in the pathogenic mechanisms of parvovirus B19 in human colorectal cancer [J]. Oncol Lett, 2014(2):523.
    Morris V K, San Lucas F A, Overman M J. Clinico-pathologic Characteristics and Gene Expression Analyses of Non-KRAS 12/13, RAS-Mutated Metastatic Colorectal Cancer [J]. ANNALS OF ONCOLOGY, 2014.
计量
  • 文章访问数: 
  • HTML全文浏览量: 
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 发布日期:  2014-10-16

目录

    /

    返回文章
    返回